Literature DB >> 6432845

Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma.

C Edelstein, J I Gordon, C A Vergani, A L Catapano, V Pietrini, A M Scanu.   

Abstract

We examined the ability of the plasma of a 52-yr-old male Tangier patient to effect the conversion of radiolabeled pro-apolipoprotein A-I (apo A-I), isolated from hepatoma cell culture media, into mature apo A-I. The conversion was assessed by amino-terminal sequence analysis, isoform patterns with two-dimensional gel electrophoresis, and a rapid assay based on the different solubilities of intact pro-apo A-I and its hexapeptide prosegment in 10% trichloroacetic acid. We found that the converting activity of Tangier plasma was comparable to that exhibited by control normolipidemic plasma and that in both cases pro-apo A-I was correctly processed at the Gln-Asp bond. After ultracentrifugal fractionation of Tangier plasma at d = 1.21 g/ml, the pro-apo A-I-to-mature apo A-I converting activity was mainly recovered in the middle fraction of d = 1.225 g/ml and was at least 10-fold more effective than the top and bottom fractions. In contrast, in normal plasma the activity was only present in the top and bottom fractions. It has been previously established that in Tangier plasma the pro-apo A-I/apo A-I ratio is significantly higher than normal (1 vs. 0.02). Our studies suggest that this abnormal ratio is not the result of a reduced converting enzyme activity and may relate to differences in turnover rates between Tangier and normal plasma apolipoproteins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432845      PMCID: PMC425269          DOI: 10.1172/JCI111477

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Rapid fractionation of human high density apolipoproteins by high performance liquid chromatography.

Authors:  D Polacek; C Edelstein; A M Scanu
Journal:  Lipids       Date:  1981-12       Impact factor: 1.880

2.  Computer-assisted analysis of two-dimensional electrophoreses of human lymphoid cells.

Authors:  E P Lester; P Lemkin; L Lipkin; H L Cooper
Journal:  Clin Chem       Date:  1980-09       Impact factor: 8.327

3.  Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.

Authors:  G Schmitz; G Assmann; S C Rall; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

4.  In vitro conversion of proapoprotein A-I to apoprotein A-I. Partial characterization of an extracellular enzyme activity.

Authors:  C Edelstein; J I Gordon; K Toscas; H F Sims; A W Strauss; A M Scanu
Journal:  J Biol Chem       Date:  1983-10-10       Impact factor: 5.157

5.  Tangier disease: a structural defect in apolipoprotein A-I (apoA-I Tangier).

Authors:  L L Kay; R Ronan; E J Schaefer; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

6.  Intracellular and extracellular processing of human apolipoprotein A-I: secreted apolipoprotein A-I isoprotein 2 is a propeptide.

Authors:  V I Zannis; S K Karathanasis; H T Keutmann; G Goldberger; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

7.  cDNA cloning of human apoA-I: amino acid sequence of preproapoA-I.

Authors:  S W Law; G Gray; H B Brewer
Journal:  Biochem Biophys Res Commun       Date:  1983-04-15       Impact factor: 3.575

8.  Human proapoA-ITangier: isolation of proapoA-ITangier and amino acid sequence of the propeptide.

Authors:  H B Brewer; T Fairwell; M Meng; L Kay; R Ronan
Journal:  Biochem Biophys Res Commun       Date:  1983-06-29       Impact factor: 3.575

9.  Proteolytic processing of human preproapolipoprotein A-I. A proposed defect in the conversion of pro A-I to A-I in Tangier's disease.

Authors:  J I Gordon; H F Sims; S R Lentz; C Edelstein; A M Scanu; A W Strauss
Journal:  J Biol Chem       Date:  1983-03-25       Impact factor: 5.157

10.  Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).

Authors:  E J Schaefer; L L Kay; L A Zech; H B Brewer
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

View more
  3 in total

1.  In vivo metabolism of proapolipoprotein A-I in Tangier disease.

Authors:  D Bojanovski; R E Gregg; L A Zech; M S Meng; C Bishop; R Ronan; H B Brewer
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

2.  Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis.

Authors:  N H Choi-Miura; T Sakamoto; S Ohtaki; H Nakamura; S Ishizawa; Y Takagi; K Gomi; M Tomita
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

3.  Tangier disease: a disorder of intracellular membrane traffic.

Authors:  G Schmitz; G Assmann; H Robenek; B Brennhausen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.